Stock 002773 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Chengdu Kanghong Pharmaceutical Group Co., Ltd

Equities

002773

CNE1000020C4

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
22.71 CNY +0.66% Intraday chart for Chengdu Kanghong Pharmaceutical Group Co., Ltd -4.02% +23.16%
04-29 Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug MT
04-29 Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug
Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug
Chengdu Kanghong Pharmaceutical Group Co., Ltd Proposes Final Cash Dividend for the Year 2023
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Kanghong Pharmaceutical's Beijing Unit Gets China's Approval for Clinical Trials for Anti-Tumor Injection
Kanghong Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug
Kanghong Pharmaceutical Gets Nod for Registration of Escitalopram Oxalate Tablets
Kanghong Pharma's Aripiprazole Oral Solution Chosen for China's Centralized Drug Procurement
Kanghong Pharma Gets FDA Nod to Trial Drug Against Fatty Liver Disease
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Kanghong Pharmaceutical Gets US FDA's Clinical Trial Nod for Antidepressant
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Executive Changes
Kanghong Pharma Gets Nod to Trial Antidepressant
Kanghong Pharma Gets Continued Protection for Traditional Chinese Medicine
Chengdu Kanghong Pharmaceutical Group Co., Ltd Announces Final Cash Dividend on Share A for 2022, Payable on June 6, 2023
Chengdu Kanghong Pharmaceutical Group Co., Ltd Approves Cash Dividend for the Year 2022
Chengdu Kanghong Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Chengdu Kanghong Pharma Wins Orphan Drug Designation in US
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002773 Stock
  4. News Chengdu Kanghong Pharmaceutical Group Co., Ltd
  5. Other languages